May 22, 2015

AAA Auto Club Group key executive John Tomlin retires
Tampa Bay Business Journal – May 22
He was recently named incoming 2015-2016 chairman of the Visit Florida board of directors, and will remain on Visit Florida’s board as “retired AAA COO,” a spokeswoman said. He also serves on the Florida Commission on Tourism and on Moffitt Cancer Center’s board of advisors.

Naveen Kumar
Tampa Bay Business Journal – May 22
Naveen Kumar will oversee the development and execution of M2Gen’s commercial activities and corporate growth strategy.

Hometown Heroes: Paddle Against Cancer
FOX-13 – May 21
With every paddle stroke, Gene Evans feels a little more at peace. He’s grateful to be alive. Despite being diagnosed with stage four kidney cancer in 2009, Gene is now cancer free, and says he has Moffitt Cancer Center to thank for saving his life.

Paddle event to benefit Moffitt
Tampa Bay Times – May 21
Gene Evans, a local paddleboarder and cancer survivor, credits a regular exercise regimen and plenty of water time for his return to health. That is why the Clearwater banker organized this weekend’s Paddle against Cancer. The action starts at 9:30 a.m. at the Club on Treasure Island. Paddlers can choose from a 3- or 7-mile paddle around Treasure Island. If you don’t want to paddle, swing by for a poolside celebration from noon to 4 p.m. All proceeds will benefit the Moffitt Cancer Center. To register, go to paddleagainstcancer.org.

Longtime Firefighter Needs Community’s Help
New Port Richey Patch – May 21
As a single mother with a 17-year-old daughter, Silva has been struggling since she reverted to inactive status on April 5, her sister said. With continuing care ongoing at Moffitt Cancer Center and the need for additional surgeries, it’s unclear just how long she’ll be without a paycheck.

AutoNation CEO joins Moffitt’s national Board of Advisors
Tampa Bay Business Journal – May 20
Mike Jackson, chairman, president and CEO of AutoNation, has been appointed to Moffitt Cancer Center’s national advisory board.

Sonographic Pattern Stratifies Thyroid Nodule Malignancy Risk
Endocrinology Advisor – May 20
“The rationale for the study in the first place was how to deal with the indeterminate cases. It has been a challenge for decades and it happens in 20% to 30% of the biopsies we do,” said study investigator Bryan McIver, MD, who is in the division of Endocrine Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida.

Sharon Baker Classic set for June 13
Greene County Daily World – May 20
The 2015 Sharon Baker Classic is scheduled for Saturday, June 13 at Southern Dunes Golf Course in Indianapolis This will be the third installment of the charity golf tournament and silent auction which benefits the Moffitt Cancer Center.

Sonographic Pattern Stratifies Thyroid Nodule Malignancy Risk
Endocrinology Advisor – May 20
“The rationale for the study in the first place was how to deal with the indeterminate cases. It has been a challenge for decades and it happens in 20% to 30% of the biopsies we do,” said study investigator Bryan McIver, MD, who is in the division of Endocrine Oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida.

Cancer diagnosis startup plans $25M investment
Business Observer – May 19
The company, Inspirata Inc., streamlines and automates the process involved in determining cancer diagnoses. Entrepreneur Satish Sanan attended the MediFuture 2023 conference two years ago, hosted by the Tampa Hillsborough Economic Development Corp., where he heard a presentation by Mark Lloyd, the scientist in charge of the H. Lee Moffitt Cancer Center & Research Institute’s analytic microscopy core laboratory. Sanan was intrigued by Lloyd’s work in the area of digital pathology and computational image analytics, according to a release.

Keytruda Shows Activity in Urothelial Cancer
Cure – May 19
“In this heavily pretreated population, Keytruda provided a median overall survival of 12.7 months and a 12-month overall survival of 54.7 percent,” says Shilpa Gupta, MD, a genitourinary oncologist at Moffitt Cancer Center in Tampa. “These results support the ongoing development of Keytruda for the treatment of urothelial cancer.”

Pembrolizumab Active in Advanced Urothelial Cancer
OncLive – May 19
“In this heavily pretreated population, pembrolizumab provided a median overall survival of 12.7 months and a 12-month overall survival of 54.7%,” Shilpa Gupta, MD, a genitourinary oncologist at Moffitt Cancer Center in Tampa. “These results support the ongoing development of pembrolizumab for the treatment of urothelial cancer.”

Provectus taking novel path to treat cancer
BioTuesdays – May 19
Mr. Culpepper says that patient enrollment was completed during the first quarter on a study of PV-10’s immunologic mechanism of action at the Moffitt Cancer Center. Following up on interim data reported in 2014, Provectus expects further study data to be reported later this year or in early 2016.

Science and Suds Meet at Sold-Out ‘Pint of Science’ Events
WUSF News “University Beat” – May 18
“Pint of Science” was created four years ago in the United Kingdom, and brought over to the U.S. last year by USF Health Molecular Pharmacology & Physiology Research Associate Parmvir Bahia and her husband, Moffitt Cancer Center researcher David Basanta.

New medical startup Inspirata sets up shop in Tampa, will hire 70
Tampa Bay Times – May 18
The company was first conceived when Sanan heard scientist Mark Lloyd, formerly of Moffitt Cancer Center's Analytic Microscopy Core laboratory, give a presentation about digital pathology at the 2013 MediFuture conference in Tampa.

Biomedical startup Inspirata to bring high-paying jobs to Tampa
The Tampa Tribune – May 18
A biotech startup company inspired by work at Moffitt Cancer Center announced Monday it will establish its corporate headquarters here and add 70 high-paying jobs over the next two years, along with $25 million in capital investment.

Tampa Chamber of Commerce positioning Tampa Bay to prosper with post-sanction Cuba
SaintPetersBlog – May 18
Christaldi also said that forging relations between officials with the two region’s airports, seaports and hospitals (members from Moffitt Cancer Center were on the trip) is also something substantive that came out of the trip.

Addressing Prostate Cancer Patients Who Experience Hot Flashes After ADT
Prostate Cancer News Today – May 18
“This study is a concrete step towards identifying which patients are more likely to experience these distressing symptoms,” said Mayer Fishman, M.D., Ph.D., senior member of Moffitt’s Genitourinary Oncology Program in a recent news release.

Moffitt Cancer Center Dedicates New Teen Lounge
Healthcare Design – May 18
Moffitt Cancer Center partnered with Teen Cancer America (TCA; Los Angeles), a program to educate and support hospitals and outpatient facilities in the development of specialized units for teens, to open a Teen and Young Adult (TYA) Lounge at its Tampa, Fla. facility.

Tampa cancer hospital opens teen lounge for patients
The Associated Press – May 17
Moffitt Cancer Center announced this week that its new teen and young adult lounge had opened. Hospital officials said they wanted the lounge to provide a homey environment. Ten percent of Moffitt’s patients are young adults.

Proposed ATA Guidelines’ Sonographic Patterns Performance for MTC
Endocrinology Advisor – May 16
“It is reassuring to us. It does predict it in the same way, and we think it is important to look at this. We don't want to miss something,” said study investigator Bryan McIver, MD, who is in the division of endocrine oncology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. 

AACR: 21st Century Cures a “Model for An Open and Honest Conversation”
The Cancer Letter – May 15
Dalton is chair of the AACR Science Policy & Government Affairs Committee, CEO of M2Gen, and director of the DeBartolo Family Personalized Medicine Institute at Moffitt Cancer Center.

Intralesional therapy for metastatic melanoma
Dermatology Times – May 14
Analyses of the blood samples showed statistically significant post-treatment increases in circulating cytotoxic CD3+/CD8+ and natural killer T-cell counts. The addition of autologous tumor cells to purified CD8+ cells obtained from the post-treatment blood sample of one patient stimulated release of interferon-gamma, the “quintessential antitumor cytokine”, said Dr. Sarnaik, surgical oncologist, department of cutaneous oncology, Moffitt Cancer Center, and assistant professor of oncology and surgery, University of South Florida, Tampa.

Final Thoughts on AML and ALL
OncLive – May 14
Jeffrey Lancet, MD,Professor of Oncologic Science and Section Chief for Leukemia, H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida

Androgen deprivation linked to cognitive impairment
Family Practice News – May 11
The results, if confirmed, suggest that discussions of the risks and benefits of androgen-deprivation therapy (ADT) should include the possibility of cognitive problems, said Brian D. Gonzalez, Ph.D., and his colleagues from the Moffitt Cancer Center in Tampa.

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.